Status:
RECRUITING
Drugs Experience for Adolescents With Anorexia
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
URC-CIC Paris Descartes Necker Cochin
Conditions:
Anorexia Nervosa
Psychotropic Drugs
Eligibility:
All Genders
12+ years
Brief Summary
The purpose of this study is to access to the experiences of adolescents, their parents and healthcare professionals regarding psychotropic drugs in anorexia nervosa. No preconceived ideas (according...
Detailed Description
Psychotropic prescription is common to adolescents suffering from anorexia nervosa. A first qualitative study (E3A Protocol "Experience of adolescents with anorexia nervosa toward antidepressants") lo...
Eligibility Criteria
Inclusion
- Adolescents :
- Aged 12 to 25 years
- Suffering from anorexia nervosa (restrictive or mixed) according to DSM-5 (Diagnostic and Statistical Manual) criteria
- Received psychotropic drugs (antidepressant treatment and/or APA) during their care, either ongoing or discontinued before this study started
- Parents of adolescents suffering from anorexia nervosa for whom a psychotropic drug has been prescribed and whose adolescents meet inclusion criteria
- Healthcare Professionals working with adolescents suffering from eating disorders
Exclusion
- Adolescents :
- Atypical eating disorder that does not meet the DSM-5 criteria for restrictive or mixed anorexia nervosa
- BMI\<15
- Prescription of an antidepressant other than an SSRI (Selective Serotonin Reuptake Inhibitor)
- Prescription of an APA for the indication of psychotic symptoms
Key Trial Info
Start Date :
May 20 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06211517
Start Date
May 20 2024
End Date
December 1 2027
Last Update
September 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maison de Solenn Maison des Adolescents, Cochin Hospital
Paris, IDF, France, 75014